Cleveland BioLabs Publishes New Insights Into Mechanism of Action of Curaxins, Extending Their Clinical Potential (Marketwire)
BUFFALO, NY–(Marketwire – November 18, 2009) – Cleveland BioLabs, Inc. ( NASDAQ : CBLI ) today announced that a breakthrough discovery into the mechanism of action of the Company’s first generation Curaxin anticancer compounds was published in an international health science journal, Cell Cycle (Neznanov et al., Cell Cycle 8:23, 1-11; December 1, 2009). The published study examined the ability …
